2052 related articles for article (PubMed ID: 8306366)
21. Serum levels of tumor necrosis factor-alpha (TNF-alpha), interleukin 6 (IL-6), and their soluble receptors in coal workers' pneumoconiosis.
Zhai R; Liu G; Ge X; Bao W; Wu C; Yang C; Liang D
Respir Med; 2002 Oct; 96(10):829-34. PubMed ID: 12412984
[TBL] [Abstract][Full Text] [Related]
22. High levels of sTNFR p75 and TNF alpha in dengue-infected patients.
Hober D; Delannoy AS; Benyoucef S; De Groote D; Wattré P
Microbiol Immunol; 1996; 40(8):569-73. PubMed ID: 8887351
[TBL] [Abstract][Full Text] [Related]
23. Cytokine activation during attacks of the hyperimmunoglobulinemia D and periodic fever syndrome.
Drenth JP; van Deuren M; van der Ven-Jongekrijg J; Schalkwijk CG; van der Meer JW
Blood; 1995 Jun; 85(12):3586-93. PubMed ID: 7780142
[TBL] [Abstract][Full Text] [Related]
24. Rapid cytokine release in cancer patients treated with interleukin-2.
Weidmann E; Bergmann L; Stock J; Kirsten R; Mitrou PS
J Immunother (1991); 1992 Aug; 12(2):123-31. PubMed ID: 1504053
[TBL] [Abstract][Full Text] [Related]
25. Tumor necrosis factor (TNF)-alpha-induced interleukin-8 in human blood cultures discriminates neutralization by the p55 and p75 TNF soluble receptors.
Frishman JI; Edwards CK; Sonnenberg MG; Kohno T; Cohen AM; Dinarello CA
J Infect Dis; 2000 Dec; 182(6):1722-30. PubMed ID: 11069245
[TBL] [Abstract][Full Text] [Related]
26. Daily alternating administration of high-dose alpha-2b-interferon and interleukin-2 bolus infusion in metastatic renal cell cancer. A phase II study.
Bergmann L; Fenchel K; Weidmann E; Enzinger HM; Jahn B; Jonas D; Mitrou PS
Cancer; 1993 Sep; 72(5):1733-42. PubMed ID: 8348502
[TBL] [Abstract][Full Text] [Related]
27. Interleukin 1 (IL-1) receptor antagonist, soluble tumor necrosis factor receptors, IL-1 beta, and IL-8--markers of remission in rheumatoid arthritis during treatment with methotrexate.
Seitz M; Loetscher P; Dewald B; Towbin H; Rordorf C; Gallati H; Gerber NJ
J Rheumatol; 1996 Sep; 23(9):1512-6. PubMed ID: 8877917
[TBL] [Abstract][Full Text] [Related]
28. Serum levels of tumor necrosis factor (TNF), soluble receptors for TNF (55- and 75-kDa sTNFr), and soluble CD14 (sCD14) in epithelial ovarian cancer.
Gadducci A; Ferdeghini M; Castellani C; Annicchiarico C; Gagetti O; Prontera C; Bianchi R; Facchini V
Gynecol Oncol; 1995 Aug; 58(2):184-8. PubMed ID: 7542621
[TBL] [Abstract][Full Text] [Related]
29. Increased levels of soluble tumor necrosis factor receptors in atherosclerosis: no clear relationship with levels of tumor necrosis factor.
Blann AD; McCollum CN
Inflammation; 1998 Oct; 22(5):483-91. PubMed ID: 9793795
[TBL] [Abstract][Full Text] [Related]
30. Differential regulation of tumour necrosis factor receptors (TNF-R) by IL-4; upregulation of P55 and P75 TNF-R on synovial joint mononuclear cells.
Cope AP; Gibbons DL; Aderka D; Foxwell BM; Wallach D; Maini RN; Feldmann M; Brennan FM
Cytokine; 1993 May; 5(3):205-12. PubMed ID: 8218932
[TBL] [Abstract][Full Text] [Related]
31. Release of soluble receptors for tumor necrosis factor (TNF) in relation to circulating TNF during experimental endotoxinemia.
Spinas GA; Keller U; Brockhaus M
J Clin Invest; 1992 Aug; 90(2):533-6. PubMed ID: 1322942
[TBL] [Abstract][Full Text] [Related]
32. Increased concentrations of tumour necrosis factor (TNF) and soluble TNF receptors in biliary obstruction in mice; soluble TNF receptors as prognostic factors for mortality.
Bemelmans MH; Greve JW; Gouma DJ; Buurman WA
Gut; 1996 Mar; 38(3):447-53. PubMed ID: 8675101
[TBL] [Abstract][Full Text] [Related]
33. High levels of serum interleukin-10 and tumor necrosis factor-alpha are associated with fatality in fulminant hepatitis.
Nagaki M; Iwai H; Naiki T; Ohnishi H; Muto Y; Moriwaki H
J Infect Dis; 2000 Oct; 182(4):1103-8. PubMed ID: 10979906
[TBL] [Abstract][Full Text] [Related]
34. Circulating soluble tumor necrosis factor receptors, interleukin-2 receptors, tumor necrosis factor alpha, and interleukin-6 levels in rheumatoid arthritis. Longitudinal evaluation during methotrexate and azathioprine therapy.
Barrera P; Boerbooms AM; Janssen EM; Sauerwein RW; Gallati H; Mulder J; de Boo T; Demacker PN; van de Putte LB; van der Meer JW
Arthritis Rheum; 1993 Aug; 36(8):1070-9. PubMed ID: 8393676
[TBL] [Abstract][Full Text] [Related]
35. Correlation between serum levels of soluble tumor necrosis factor receptor and disease activity in systemic lupus erythematosus.
Aderka D; Wysenbeek A; Engelmann H; Cope AP; Brennan F; Molad Y; Hornik V; Levo Y; Maini RN; Feldmann M
Arthritis Rheum; 1993 Aug; 36(8):1111-20. PubMed ID: 8393677
[TBL] [Abstract][Full Text] [Related]
36. Serum levels of soluble receptors for tumor necrosis factor (p55 and p75 sTNFr) in endometrial cancer.
Gadducci A; Ferdeghini M; Fanucchi A; Annicchiarico C; Prato B; Prontera C; Facchini V; Genazzani AR
Anticancer Res; 1996; 16(5B):3125-8. PubMed ID: 8920779
[TBL] [Abstract][Full Text] [Related]
37. [Hyperdynamic hemodynamics following high-dose interleukin 2-interferon alpha therapy in patients with metastatic renal cell carcinoma. Immunotherapy as a clinical sepsis model?].
Finck-Seelen ; Lampert R; Brandt L
Anaesthesist; 1996 Dec; 45(12):1171-8. PubMed ID: 9065251
[TBL] [Abstract][Full Text] [Related]
38. Soluble tumor necrosis factor receptors in chronic hepatitis C: a correlation with histological fibrosis and activity.
Zylberberg H; Rimaniol AC; Pol S; Masson A; De Groote D; Berthelot P; Bach JF; Bréchot C; Zavala F
J Hepatol; 1999 Feb; 30(2):185-91. PubMed ID: 10068094
[TBL] [Abstract][Full Text] [Related]
39. Cytokine levels and systemic toxicity in patients undergoing isolated limb perfusion with high-dose tumor necrosis factor, interferon gamma, and melphalan.
Thom AK; Alexander HR; Andrich MP; Barker WC; Rosenberg SA; Fraker DL
J Clin Oncol; 1995 Jan; 13(1):264-73. PubMed ID: 7799030
[TBL] [Abstract][Full Text] [Related]
40. Serum levels of p55 and p75 soluble TNF receptors in adult acute leukaemia at diagnosis: correlation with clinical and biological features and outcome.
Vinante F; Rigo A; Tecchio C; Morosato L; Nadali G; Ricetti MM; Krampera M; Zanolin E; Locatelli F; Gallati H; Chilosi M; Pizzolo G
Br J Haematol; 1998 Sep; 102(4):1025-34. PubMed ID: 9734654
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
